Valuation: QuidelOrtho Corporation

Market Cap 1.03B 897M 841M 767M 1.44B 98.76B 1.47B 9.9B 3.87B 49.44B 3.88B 3.8B 165B P/E 2026 *
-3.43x
P/E 2027 * -4.39x
Enterprise Value 3.59B 3.11B 2.92B 2.66B 5.01B 343B 5.09B 34.38B 13.42B 172B 13.49B 13.2B 573B EV / Sales 2026 *
1.41x
EV / Sales 2027 * 1.37x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day+1.75%
1 week-7.54%
Current month-10.02%
1 month-15.65%
3 months+36.56%
6 months-36.01%
Current year-47.16%
1 week 12.07
Extreme 12.0657
15.52
1 month 11.41
Extreme 11.41
19.03
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
84.6
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
7/1/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
+1.75%-7.54%-44.28%-80.64% 1.03B
-0.38%+2.44%+19.67%-34.77% 17.03B
+4.18%+7.69%-5.04%+100.09% 1.82B
-0.73%+0.37%-30.11%+21.88% 985M
+0.27%+51.02%+73.06%-11.23% 780M
-0.17%+4.04%-37.47%-50.56% 690M
-2.04%+17.06%-41.55%-43.49% 622M
+0.44%+5.11%-44.57%-43.32% 417M
+0.90%+21.81%+43.40%+40.22% 418M
0.00%+3.11%-7.75%-22.64% 380M
Average +0.42%+8.46%-7.46%-12.45% 2.42B
Weighted average by Cap. +0.07%+3.85%+10.44%-22.87%

Financials

2026 *2027 *
Net sales 2.54B 2.2B 2.06B 1.88B 3.54B 242B 3.6B 24.31B 9.49B 121B 9.54B 9.33B 405B 2.58B 2.24B 2.1B 1.91B 3.6B 246B 3.66B 24.7B 9.64B 123B 9.69B 9.48B 411B
Net income -272M -236M -221M -202M -379M -25.98B -386M -2.6B -1.02B -13.01B -1.02B -1B -43.38B -172M -149M -140M -128M -240M -16.44B -244M -1.65B -644M -8.23B -647M -633M -27.46B
Net Debt 2.56B 2.22B 2.08B 1.9B 3.57B 244B 3.62B 24.48B 9.56B 122B 9.6B 9.4B 408B 2.49B 2.16B 2.02B 1.85B 3.47B 238B 3.53B 23.83B 9.3B 119B 9.35B 9.15B 397B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-08-13 US$15.09 +1.75% 1,446,395
26-08-12 US$14.83 +6.00% 1,953,334
26-08-11 US$13.99 +1.75% 1,495,558
26-08-10 US$13.75 +11.93% 2,808,677
26-08-07 US$12.29 -24.72% 4,890,329
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
15.09USD
Average target price
12.00USD
Spread / Average Target
-20.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock